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Abstract
Infectious pathologies are a group of diseases that contribute with great impact on pub-
lic health worldwide. Among the various diseases, some have a higher epidemiological 
importance, since their morbidity and mortality are very significant. In addition to the 
usual immune response, mounted against noxious agents, there is still the concept of 
infection-induced autoimmunity. Autoimmune diseases are defined as illnesses in which 
the evolution from benign to pathogenic autoimmunity takes place. However, proving 
a disease to be of autoimmune etiology is not a simple task. It is well known that both 
genetic influences and environmental factors trigger autoimmune disorders. However, 
some theories are still under great discussion. One of the most intriguing self-induced 
disorders is the hypothesis of autoimmunity during Chagas disease. Since the mid-1970s, 
the Chagas autoimmunity hypothesis has been considered an important contributor to 
the complex immune response developed by the host and triggered by Trypanosoma cruzi. 
New ideas and findings have strengthened this hypothesis, which has been reported in a 
series of publications from different groups around the world. The aim of this chapter is 
to discuss the mechanisms involving autoimmunity development during Chagas disease.
Keywords: Chagas disease, autoimmunity, T. cruzi, autoantibodies, immunology, 
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1. Introduction
Autoimmune diseases are chronic disabling disorders described as immune responses against 
self-antigens that comprise cells, tissues, and organs, resulting in devastating consequences 
for patients [1]. For over decades, the concept of autoimmune disease has been studied, and 
the relationship between infectious diseases and autoimmunity has been established. Among 
all illnesses, Chagas disease has caught the attention of many researchers worldwide. Along 
with all the possible pathogenic mechanisms involved in Trypanosoma cruzi infection, the 
autoreactive hypothesis has been discussed over the years and plays an important role in the 
cardiac damage presented by Chagas patients. This chapter intends to explore the T. cruzi-
induced autoimmunity hypothesis by discussing its pathogenic mechanisms and its potential 
role in the tissue aggravation during Chagas disease.
2. Autoimmunity: an obscure immunological path
In order to understand autoimmunity, it is essential to go back into the first steps of T- and 
B-cell development, differentiation, and maturation. During the process of generation of new 
lymphocytic clones derived from a stem cell, a novel lymphocyte carrying a specific pattern 
of B-cell receptor (BCR) or T-cell receptor (TCR) is formed as revised recently [2, 3]. While 
B-lymphocytes may undergo full maturation in the bone marrow, T lymphocytes need thy-
mic education, as can be observed in Figure 1.
After egressing the bone marrow, T lymphocytes undergo differentiation and maturation 
in the thymus in which they pass through a process called negative and positive selection 
[4, 5].
Positive selection occurs during classical thymic differentiation, in which thymocytes may 
generate naive conventional T lymphocytes. These cells migrate to peripheral tissues and 
further differentiate in response to encounter with nonself-antigens. The negative selection 
is based on the elimination or inhibition of “self-reactive” cells. Nevertheless, some of these 
self-reactive T cells could escape negative selection and might become activated during the 
inflammatory process. On the other hand, a second or agonist-driven thymic selection, was 
proposed in which specialized T-cell subsets are generated from thymocytes that bind with 
high avidity to self-antigens. In this case, these cells leave the thymus as antigen-experienced 
activated T cells, such as double-negative TCRαβ+ intestinal T cells, CD8αα+, invariant iNKT, 
Foxp3+ nTreg cells, TH17 cells [6] and possibly mucosal associated invariant T cells (MAIT) 
[7]. Two barriers for self-reactive cells exist, which are the central and peripheral tolerance [5]. 
Failure in these processes may allow the proliferation of self-reactive clones, thus establishing 
an autoimmune pathogenic disease. Genetic disorders as well as environmental conditions 
can trigger the failure on central or peripheral tolerance, [8–12]. In addition, other pathways 
can lead to autoimmunity such as molecular similarity or mimicry, specific epitope spread-
ing, indirect or bystander activation, B- and T-cell polyclonal activation, infections, and self-
inflammatory activation that trigger innate immunity [8, 13].
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3. Chagas disease: an outburst of inflammatory events that may lead to 
autoimmunity
T. cruzi is a haemoflagellate parasite transmitted by several species of triatomine bugs. The 
best known mood of transmission is the vetorial via, which consists of vector insects ingest-
ing contaminated blood meal containing bloodstream trypomastigotes. Later on, inside the 
insect’s gut, the parasite differentiates into epimastigotes and replicates. The cycle is complete 
once the insect defecates, and releases metacyclic trypomastigotes forms which invade the host 
through the bite wound or mucosal membranes. Chagas disease progresses from a somewhat 
asymptomatic short acute phase to a chronic phase. Most individuals that progress to chronic 
phase remain asymptomatic, and the disease is detected by serological tests, but no clinical, 
radiologic, electrocardiographic, or echocardiographic evidenced. Overall, 20–40% of asymp-
tomatic individuals develop clinically relevant Chagas heart disease, while approximately 10% 
Figure 1. Dynamics of hematopoiesis, maturation and recirculation of newly generated lymphocytes as well as thymic 
selection of T-cell clones.
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of the cases progress to digestive problems [14, 15]. In fact, the disease outcome toward differ-
ential clinical forms is related to many factors including the host-parasite interaction. Several 
studies have been proposed that the host immunological response plays a major role in the 
pathogenesis of Chagas disease [16]. Indeed, the T. cruzi can trigger an immune response, since 
parasite antigen has been consistently found in heart tissue infiltrated from cardiac patients 
[17, 18]. Nevertheless, the divergence between low parasite load in the tissue and severity of 
the lesions observed during the chronic phase reinforces the hypothesis that other factors than 
the immune response developed against the parasite might be involved in the development 
of Chagas pathology [19]. In this context, humoral and cellular autoimmune mechanisms are 
developed during Chagas disease [20–23]. Autoimmune mechanisms triggered during infec-
tion by T. cruzi may occur after bystander activation, parasite-cardiomyocyte harm, or molecu-
lar mimicry [24]. The mechanisms discussed in this chapter are schematically summarized in 
Figure 2.
Figure 2.  Scheme of the probable mechanisms involved in the autoimmune pathogenesis of Chagas disease.
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Since T. cruzi presents a high variability of surface antigens, it is possible that the parasite 
causes polyclonal activation, which involves the T-independent stimulation of self-reactive B 
lymphocytes [25]. The lipopolysaccharide has been described as polyclonal activator, which 
induces the hypergammaglobulinemia phenomenon with higher secretion of autoantibod-
ies, mainly IgM isotype [26]. Furthermore, T. cruzi-derived antigens can activate B1 lympho-
cytes before the development of T-cell-mediated immune response during the early stages 
of Chagas disease. [27, 28]. High percentage of B1 cells are found in the peripheral blood of 
chronic Chagas patients, as well as a significant decrease in the percentage of CD3+ T cells 
[27, 28]. Additional studies have demonstrated that auto-anti-idiotypic antibodies (Ids) from 
chagasic cardiac disease patients preferentially stimulate B1 cells and CD8+ T cells in magni-
fied proportion as compared to indeterminate patients [29, 30]. The lower levels of T cells 
in the peripheral blood of chagasic cardiac patients suggest that T-cell-mediated immunity 
should be restricted to inflammatory foci, considering previous reports of the presence of T 
cells, mainly CD8+ T lymphocytes, in the inflammatory infiltrate of cardiac tissue from indi-
viduals infected by T. cruzi [16]. A study using murine experimental model based on infec-
tion by T. cruzi demonstrated that the onset of cytokine production by T cells in the cardiac 
tissue is correlated with the local increase in the expression of cell adhesion molecules that 
is consistent with the T-lymphocyte migration to the inflammatory milieu [31]. In this study, 
the authors propose that chronic inflammation in the cardiac tissue from Chagas disease 
patients is highly active and is related to a permanent proinflammatory immune pattern that 
extends from the recent acute phase to the late stages of the chronic phase. Indeed, it is well 
accepted that the absence of pathology in individuals infected by T. cruzi is associated with 
the individual’s ability to regulate the anti-T. cruzi response, which is responsible for the 
control of persistent parasitemia and tissue inflammatory damage, characteristic of Chagas 
disease [16, 32–34]. Certainly, the tissue inflammatory damage should be more severe in the 
absence of regulatory mechanisms involving both innate and adaptive immune responses. 
Indeed, our group has reported that in the indeterminate clinical form of Chagas disease, 
there is a higher frequency of CD4+CD25High T cells and NKT lymphocytes than individuals 
with cardiac disease [35, 36]. As CD4+CD25High T cells and NKT lymphocytes showed an 
important role in modulating the activation of CD8+ T cells via apoptosis, as well as through-
out the secretion of regulatory cytokines, it is possible that these cells during indeterminate 
clinical state further contribute to the control of the cytotoxic activity and deleterious events 
mediated by CD8+ T cells [37, 38]. It is worth to mention that a fine equilibrium between 
inflammatory and regulatory cytokines represents a crucial element in the establishment of 
distinct clinical forms of chronic Chagas disease [33, 38]. It has been demonstrated that in the 
severe cardiac clinical status, leucocytes produce more IFN-gamma, while IL-10 is predomi-
nantly produced by PBMCs from indeterminate [38, 39].
In this regard, the functional role of peripheral blood leukocytes in patients infected by T. cruzi, 
after antigen stimulation has demonstrated that the main source of IFN-γ in cardiac patients 
is CD4+ T lymphocytes, while monocytes are responsible for the production of high levels of 
IL-10 in patients with indeterminate status, favoring the regulation of the immune response 
and the control of disease morbidity [40]. It is possible that regulatory T cells are involved in 
this process, since they can inhibit the synthesis of IFN-γ, which could explain the low levels of 
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this cytokine produced by T cells from indeterminate Chagas disease patients. In this context, it 
is important to reinforce that the inflammatory environment and cell destruction induced by T. 
cruzi infection could alter and induce antigen processing/presentation in such a way that novel 
self-epitopes are generated and recognized by the immune system, namely, cryptic epitope 
[41]. In steady state, the cryptic epitope displays low affinity for MHC molecules and is rarely 
presented by somatic cells, while dominant peptides show a high affinity for MHC molecules 
and are frequently presented by somatic cells. Furthermore, CD8+ T cells specific for cryptic 
epitope could escape from the negative selection process in central tolerance [42]. Despite the 
fact that this process during T. cruzi infection is not yet clearly understood, this mechanism 
has been demonstrated to be involved in the pathogenesis of other autoimmune diseases [43]. 
Moreover, it has been shown that antigen processing and presentation were altered after the 
in vitro IFN-γ treatment, strengthening the hypothesis that the higher levels of IFN-γ in car-
diac patients may favor the establishment of autoimmune mechanisms during Chagas disease. 
Indeed, the bystander activation mechanism caused by massive host antigens released in a 
proinflammatory environment may stimulate autoimmunity during T. cruzi infection.
4. The autoimmunity during Chagas disease: theories, concepts, and 
mechanisms triggered by Trypanosoma cruzi
Starting from the innate response, the human organism defends itself in a variety of ways. 
Physical barriers, phagocytic cells, (such as macrophages and dentritic cells), natural killer 
cells, neutrophils and the complement system are just a few examples of how precise and 
efficient our body reacts. Besides the innate response, the immune system is comprised of the 
adaptive response, a complex compartment of defense. Leucocytes (T and B lymphocytes), 
antibodies, and many other molecules are constantly working in order to keep the homeo-
stasis. Furthermore, another important mechanism that is part of the immunological system 
is the autoimmunity concept. The autoimmunity concept started when researchers proposed 
that T. cruzi infection promoted rejection of allogeneic heart cell transplants and that T lym-
phocytes from T. cruzi-infected animals rapidly destroyed embryonic cardiomyocytes in cul-
ture [44]. However, reports that protective T. cruzi-specific T-cell-mediated immunity could 
be induced without eliciting pathogenic autoimmunity were soon published.
The debate about a role for autoimmunity in Chagas disease continued. Autoreactive T cells 
and antibodies were identified in individuals with chronic Chagas disease, and several specific 
antigens abundant in the myocardium were identified as targets of autoreactive responses [22, 
45, 46]. Inflammatory factors present in the local environment, such as cytokines and nitric 
oxide, were also found to promote the activation of potentially autoreactive T cells encounter-
ing major histocompatibility complex-bound cognate antigen [21, 47, 48]. In this context, the 
autoimmune hypothesis plays a crucial role in the pathogenesis of many infectious diseases, 
including Chagas. The mechanisms proposed in this section for the generation of autoimmunity 
during Chagas disease are mimicry, indirect or bystander activation, and epitope spreading.
Mimicry is defined by the development of immune responses against foreign antigens that 
share sequence or structural similarities with self-antigens. This is due to the fact that immune 
responses can be directed against peptides with similar charge distribution and shape [8]. 
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This mechanism suggests that T. cruzi-induced cardiac damage and/or molecular mimicry 
between parasite and host antigens leads to a breakdown in self-tolerance, resulting in even-
tual tissue damage [49]. Two cardiac molecules that have been related to the induction of 
Chagas autoimmune responses are myosin and troponin I [50, 51]. Troponin I have been 
recently described in T. cruzi-naturally infected macaques, which present high titers of tropo-
nin I autoantibodies in their circulatory system. In regards to myosin, it is the most abundant 
protein in the heart and may represent a significant cardiac antigen. Several studies have 
demonstrated the presence of autoantibodies against this protein circulating in the sera of 
Chagas disease experimental models [41, 52, 53]. Its potential to become an antigen mimicry 
candidate has been under discussion for over decades, especially considering several studies, 
which have linked it to the autoimmune hypothesis. Furthermore, a robust myosin-specific 
autoimmunity as well as immune tolerization to myosin suppresses parasite-specific immu-
nity [41, 53]. However, it seems that myosin-specific autoimmunity itself is not essential to 
establish an inflammation [54].
In addition, other host antigens have been studied and proved to cross-react with T. cruzi 
proteins, such as B1 and B2 adrenoreceptors, lymphocyte, neuronal tissues, muscle antigens, 
m2 muscarinic acetylcholine receptors, small nuclear ribonucleoprotein, and Cha, a novel 
autoantigen [22, 55]. Moreover, some T. cruzi proteins have also been identified as potential 
antigen mimicry candidates, like epitopes of B13, 24-kDa, 36-kDa, 38-kDa, ribosomal P1 and 
P2 proteins, the shed acute-phase antigen (SAPA), and the T. cruzi cysteine protease cruzipain 
[22, 51, 55–59]. Worthy of mentioning was the identification of three regions of homologous 
linear sequence among cruzipain and myosin as well as the partial homology displayed in 
ribosomal P protein internal peptide sequence between T. cruzi and humans. These findings 
provide more evidence that the molecular mimicry mechanism may stimulate autoimmunity 
and strengths the hypothesis.
An additional concept of great discussion is the bystander activation. During microbial infec-
tion, toll-like receptors (TLRs) and pattern recognition receptors present on antigen-pre-
senting cells (APCs) are stimulated leading to the synthesis and release of proinflammatory 
mediators. Together with self-antigens, coming from tissue destruction and creating a milieu 
of proinflammatory factors, all of these mediators may defeat self-tolerance by decreasing the 
threshold of activation enough to activate potentially autoreactive T cells and trigger autoim-
munity. Furthermore, CD8+ T cells may also initiate bystander activation by proliferating in 
response to self-antigen presented by APCs [21, 49, 60]. Hyland et al. [61] have shown that 
a reduction in parasitemia via treatment with Benznidazole, decreased or eliminated myo-
sin-specific autoimmunity. They hypothesized that reduction of parasitemia consequently 
reduces release of host antigens and also dampens the inflammatory environment lessening 
bystander activation. Altogether, these data bring great perspectives to elucidate the autoim-
mune hypothesis of Chagas disease.
Subsequent to bystander activation, there is the development of autoimmune responses to 
endogenous epitopes secondary to the release of self-antigens, the so-called epitope spread-
ing. It results from a change in protein structure, for example, changing of an amino acid from 
arginine to citrulline, which may succumb in an immune reaction against either the original 
protein or the citrullinated protein. Some of the mechanisms involved in epitope spreading 
are endocytic processing, antigen presentation, and somatic hypermutation, all culminating 
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in broadening the immune response in autoimmune pathologies. Several authors have dem-
onstrated the epitope spreading against many cardiac proteins, such as myosin, Cha protein, 
desmin, actin, myoglobin, tubulin, and B1 adrenergic receptor [49, 55, 62]. Still, more studies 
must be conducted in order to prove that this mechanism fully contributes to the propagation 
of autoimmunity in Chagas disease.
5. Final remarks
Chagas disease afflicts millions of people each year worldwide. Some individuals present 
mild to moderate symptoms during the chronic phase, while others develop severe and life-
threatening cardiac and digestive conditions. There have been great advances in understand-
ing the physiopathology of Chagas heart disease, which may contribute to the evolution in 
the field of drug development and therapy approaches. Apparently the auto-reactive cells 
are great responsible for destruction of the cardiac tissue leading to cardiac failure, the most 
severe consequence of the disease. Although the data describing the existence of T. cruzi-
induced autoimmunity continues to grow, there is still lack of direct evidencere ported in 
the literature. Elucidating the autoimmune hypothesis of Chagas disease may help to solve 
potential complications for Chagas disease treatments involving autoimmunity, as well as to 
better understand many questions that remain unanswered about Chagas disease pathogen-
esis. Moreover, this hypothesis may serve as a model for studying infection-induced autoim-
munity, which may be applicable to proposing and investigating new immune therapies for 
autoimmune diseases.
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